# Effect of Empagliflozin on Heart Failure Outcomes After Acute Myocardial Infarction: Insights From the EMPACT-MI Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effect-of-empagliflozin-on-heart-failure-outcomes-after-acute-myocardial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Adrian F. Hernandez,Jacob A. Udell,W. Schuyler Jones,Stefan D. Anker,Mark C. Petrie,Josephine Harrington,Michaela Mattheus,Svenja Seide,Isabella Zwiener,Offer Amir,M. Cecilia Bahit,Johann Bauersachs,Antoni Bayés‐Genís,Yundai Chen,Vijay Chopra,Gemma A. Figtree,Junbo Ge,Shaun G. Goodman,Nina Gotcheva,Shinya Goto,Tomasz Gąsior,Waheed Jamal,James L. Januzzi,Myung Ho Jeong,Yu. M. Lopatin,Renato D. Lópes,Béla Merkely,Puja B. Parikh,Alexander Parkhomenko,Piotr Ponikowski,Xavier Rosselló,Morten Schou,Dragan Šimić,Philippe Gabríel Steg,Joanna Szachniewicz,Peter van der Meer,Dragoş Vinereanu,Shelley Zieroth,Martina Brueckmann,Mikhail Sumin,Deepak L. Bhatt,Javed Butler |
| Citations | 95 |
| DOI | 10.1161/circulationaha.124.069217 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1161/circulationaha.124.069217 |
| OpenAlex ID | https://openalex.org/W4394014497 |
| PMID | 38581389 |
| Type | article |
| Year | 2024 |

## Paper authors

- [James L. Januzzi](https://scholariq.org/researchers/james-l-januzzi/)
- [Philippe Gabríel Steg](https://scholariq.org/researchers/philippe-gabriel-steg/)
- [Stefan D. Anker](https://scholariq.org/researchers/stefan-d-anker/)
- [Deepak L. Bhatt](https://scholariq.org/researchers/deepak-l-bhatt/)
- [Piotr Ponikowski](https://scholariq.org/researchers/piotr-ponikowski/)

## Paper funders

Showing 8 of 17.

- [Amgen](https://scholariq.org/funders/amgen/)
- [Bristol-Myers Squibb](https://scholariq.org/funders/bristol-myers-squibb/)
- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)
- [Pfizer](https://scholariq.org/funders/pfizer/)
- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [Sanofi](https://scholariq.org/funders/sanofi/)
- [Alnylam Pharmaceuticals](https://scholariq.org/funders/alnylam-pharmaceuticals/)
- [CSL Behring](https://scholariq.org/funders/csl-behring/)

## Paper journal

- [Circulation](https://scholariq.org/journals/circulation/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Hyperglycemia and glycemic control in critically ill and hospitalized patients](https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.